Clinical Research Directory

Browse clinical research sites, groups, and studies.

2 clinical studies listed.

Healthy volunteers

Filters:

Hepatomegaly

Tundra lists 2 Hepatomegaly clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT03801434

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-01

4 states

BCR-JAK2 Fusion Protein Expression

Blasts 20 Percent or Less of Peripheral Blood White Cells

Blasts More Than 5 Percent of Bone Marrow Nucleated Cells

RECRUITING

NCT07068191

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

This study compares the effectiveness of the dietary supplement Gepaktiv with standard medications (UDCA and Ademetionine) in patients with fatty liver disease (MAFLD) and liver enlargement (hepatomegaly). Key points: * Participants will receive either Gepaktiv, UDCA, or Ademetionine for 15 days * Doctors will monitor liver health through blood tests and ultrasound scans * The study will check if Gepaktiv helps improve liver function as effectively as standard treatments. Main measurements: * Changes in liver enzyme levels (ALT, AST) * Reduction in liver size * Improvement in fat accumulation (steatosis) measured by FibroScan This research may provide evidence for a new natural option to support liver health.Data analysis will be done by an independent biostatistics

Gender: All

Ages: 18 Years - 65 Years

Updated: 2025-07-23

1 state

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

Hepatomegaly

Nonalcoholic Fatty Liver (NAFL)